BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 10077238)

  • 21. Effects of a mu-opioid receptor agonist on G-protein activation in streptozotocin-induced diabetic mice.
    Ohsawa M; Mizoguchi H; Narita M; Kamei J; Nagase H; Tseng LF
    Eur J Pharmacol; 2000 Jul; 401(1):55-8. PubMed ID: 10915837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application].
    Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):107-16. PubMed ID: 9866825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
    Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
    Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
    Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
    J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
    Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR; Nahorski SR
    Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice.
    Hosohata Y; Vanderah TW; Burkey TH; Ossipov MH; Kovelowski CJ; Sora I; Uhl GR; Zhang X; Rice KC; Roeske WR; Hruby VJ; Yamamura HI; Lai J; Porreca F
    Eur J Pharmacol; 2000 Feb; 388(3):241-8. PubMed ID: 10675732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice.
    Doğrul A; Yeşilyurt Ö; Işmer A; Güzeldemir EM
    Pain; 2001 Jul; 93(1):61-68. PubMed ID: 11406339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
    Xie H; Woods JH; Traynor JR; Ko MC
    Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional differences in mu and kappa opioid receptor G-protein activation in brain in male and female prairie voles.
    Martin TJ; Sexton T; Kim SA; Severino AL; Peters CM; Young LJ; Childers SR
    Neuroscience; 2015 Dec; 311():422-9. PubMed ID: 26523979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
    J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
    Childers SR; Xiao R; Vogt L; Sim LJ
    Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
    Breivogel CS; Selley DE; Childers SR
    J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of mu-opioid receptor-mediated G-protein activation in the pons/medulla of mice lacking the exons 2 and 3 of mu-opioid receptor gene.
    Mizoguchi H; Wu HE; Narita M; Loh HH; Nagase H; Tseng LF
    Neurosci Lett; 2002 Dec; 335(2):91-4. PubMed ID: 12459506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.